Get the app
US › Healthcare

Tectonic Therapeutic, Inc. (TECX)

US · Healthcare · Biotechnology

$27.21-2.51%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-22.3M
EPS
$-1.18
EPS estimate
$-1.41

EPS came in at -1.18 against a street estimate of -1.41 — a beat of 16.3%.

Key statistics

Market cap
$559.3M
Forward P/E
0.0
P/B
2.65
Book value
$12.24
EPS (TTM)
$-4.30
52-week high
$39.53
52-week low
$14.38
50-day MA
$32.91
200-day MA
$27.48
Beta
0.22

Analyst view

Analysts rate Tectonic Therapeutic, Inc. a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $77.56.

Shareholding

Insiders
37.85%
Institutions
71.69%

Largest institutional holders

FundStake
FMR Inc14.41%
TCG Crossover Management, LLC6.16%
Aberdeen Group PLC5.84%
BlackRock Inc4.40%
BRAIDWELL LP4.33%
First Light Asset Management, LLC4.10%
Baker Bros Advisors LP3.11%
5AM Venture Management, LLC3.10%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tectonic Therapeutic, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.